Article
Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949
2019-03-08
Abstract excerpt
Despite the steadily increased numbers of formyl peptide receptor (FPR) ligands identified over the years, few have been characterized in studies using animal disease models and even less have entered clinical trials in human subjects. A small-molecule compound, Act-389949, was however recently tested in a phase I clinical trial and found to be safe and well tolerated in healthy human subjects. The desired anti-in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6c6b6e2f-0293-5bbb-9378-6a655baaed3f
- DOI
- 10.1101/571604
